This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

28 Jun 2017

BASF plans significant investment in ibuprofen capacities in Germany and North America

New world-scale ibuprofen production plant in Ludwigshafen; additional capacity expansion of ibuprofen plant in Bishop, Texas.

BASF plans to build a new world-scale plant to produce ibuprofen in Ludwigshafen, Germany.The new plant, is scheduled to come onstream in 2021. “It will be the first world-scale ibuprofen plant in Europe,” says Dr Markus Kamieth, Member of the Board of Executive Directors, BASF SE. With this investment, BASF aims to ensure high supply security for its customers and meet growing global demand.

BASF is also expanding its ibuprofen capacities at its production site in Bishop, Texas, to fill current supply gaps for ibuprofen in the market. The expansion will come onstream in early 2018. The company will invest approximately €200 million in both projects.

“BASF will be the only supplier with two ibuprofen assets worldwide. This makes us a highly reliable partner for our customers,” says Kamieth.

“Both investments show our strong commitment to the pharmaceutical industry and our pharma solutions business,” says Dr Melanie Maas-Brunner, President of BASF’s Nutrition & Health business. “They enable us to close supply gaps and efficiently support our customers’ growth plans.”

Related News